Occl Ltd vs Sree Rayalaseema Hi Strength Hypo Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Mar 23, 2026

Key Highlights

The Latest Trading Price of OCCL Ltd is ₹ 83.62 as of 23 Mar 15:30 . The P/E Ratio of OCCL Ltd changed from 0 on March 2021 to 0 on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe P/E Ratio of Sree Rayalaseema Hi-Strength Hypo Ltd changed from 6.7 on March 2021 to 9.4 on March 2025 . This represents a CAGR of 7.01% over 5 years The Market Cap of OCCL Ltd changed from ₹ 0 crore on March 2021 to ₹ 0 crore on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe Market Cap of Sree Rayalaseema Hi-Strength Hypo Ltd changed from ₹ 405.69 crore on March 2021 to ₹ 845.2 crore on March 2025 . This represents a CAGR of 15.81% over 5 years The revenue of OCCL Ltd for the Dec '25 is ₹ 0 crore as compare to the Sep '25 revenue of ₹ 0 crore. This represent the decline of 0% The revenue of Sree Rayalaseema Hi-Strength Hypo Ltd for the Dec '25 is ₹ 160.58 crore as compare to the Sep '25 revenue of ₹ 189.49 crore. This represent the decline of -15.26% The ebitda of OCCL Ltd for the Dec '25 is ₹ 0 crore as compare to the Sep '25 ebitda of ₹ 0 crore. This represent the decline of 0% The ebitda of Sree Rayalaseema Hi-Strength Hypo Ltd for the Dec '25 is ₹ 36.45 crore as compare to the Sep '25 ebitda of ₹ 34.05 crore. This represent the growth of 7.05% The net profit of OCCL Ltd changed from ₹ 0 crore to ₹ 0 crore over 7 quarters. This represents a CAGR of 0.0% The net profit of Sree Rayalaseema Hi-Strength Hypo Ltd changed from ₹ 18.62 crore to ₹ 23.75 crore over 7 quarters. This represents a CAGR of 14.92% The Dividend Payout of OCCL Ltd changed from 34.98 % on March 2025 to 34.98 % on March 2025 . This represents a CAGR of 0.00% over 1 yearsThe Dividend Payout of Sree Rayalaseema Hi-Strength Hypo Ltd changed from 8.5 % on March 2021 to 5.55 % on March 2025 . This represents a CAGR of -8.17% over 5 years .

About OCCL Ltd

OCCL Limited was incorporated on April 25, 2022, at Mundra, Kachchh, Gujarat with a Certificate of Incorporation issued by the RoC. The Company belongs to the AG Ventures Group of companies.
The Company's first insoluble sulphur manufacturing facility, (transferred from demerged entity), was set up in 1994 in Dharuhera to manufacture insoluble sulphur, now its flagship product. The Company manufactures commercial grade and battery grade sulphuric acid and oleum at its Dharuhera Plant.
The Company's state-of-the-art manufacturing facilities are located in Dharuhera in Haryana and Mundra in Gujarat. The Company commenced production of Sulphuric Acid in 1978; commenced production capacity of 3,000 MT per annum Insoluble Sulphur in 1994; established a second line of business at Dharuhera in 2005; commenced construction of plant at Mundra in 2009; commissioned the first line of 5500 MTPA at Mundra Plant in 2011; commissioned the second line of insoluble sulphur at Mundra with production capacity of 5500 MTPA in 2012; expanded the additional 11,000 TPA of insoluble sulphur capacity at Mundra in 2016; commissioned the third line of insoluble sulphur with installed capacity of 5500 MTPA at Mundra Plant in 2017; commissioned the fourth line of insoluble sulphur with 5500 MTPA at Mundra in 2018; commissioned the expansion of 5500 MTPA insoluble sulphur at Dharuhera Plant in 2021; commissioned an additional 42000 MTPA capacity of sulphuric acid at Dharuhera Plant in 2022.

About Sree Rayalaseema Hi-Strength Hypo Ltd

Sree Rayalaseema Hi-Strength Hypo Limited was incorporated in March, 2005.
The Company is the leading producer of Calcium Hypo Chloride, Stable Bleaching Powder, Sulphuric Acid and Other Chemicals. Sree Rayalaseema Hi-Strength Hypo, the torch bearer of the conglomerate, is the only Indian manufacturer of Calcium Hypochlorite, and one of the very few in the world.
A state-of-the-art sodium process technology developed through in-house R&D efforts helps the company in manufacturing the product with a chlorine content of 65% to 70%. The business of manufacturing of industrial chemicals was vested in the Company effective on 1st April, 2005 through Scheme of Arrangement in June, 2006 and generation of Wind Energy in 2008. The Company products can be broadly classified under Inorganic chemicals.

FAQs for the comparison of OCCL Ltd and Sree Rayalaseema Hi-Strength Hypo Ltd

Which company has a larger market capitalization, OCCL Ltd or Sree Rayalaseema Hi-Strength Hypo Ltd?

Market cap of OCCL Ltd is 438 Cr while Market cap of Sree Rayalaseema Hi-Strength Hypo Ltd is 742 Cr

What are the key factors driving the stock performance of OCCL Ltd and Sree Rayalaseema Hi-Strength Hypo Ltd?

The stock performance of OCCL Ltd and Sree Rayalaseema Hi-Strength Hypo Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for OCCL Ltd and Sree Rayalaseema Hi-Strength Hypo Ltd?

As of March 23, 2026, the OCCL Ltd stock price is INR ₹87.85. On the other hand, Sree Rayalaseema Hi-Strength Hypo Ltd stock price is INR ₹432.75.

How do dividend payouts of OCCL Ltd and Sree Rayalaseema Hi-Strength Hypo Ltd compare?

To compare the dividend payouts of OCCL Ltd and Sree Rayalaseema Hi-Strength Hypo Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.